These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8834481)

  • 1. Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain.
    Rahimian R; Hrdina PD
    Can J Physiol Pharmacol; 1995 Dec; 73(12):1686-91. PubMed ID: 8834481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
    Mann CD; Vu TB; Hrdina PD
    Br J Pharmacol; 1995 Jun; 115(4):595-600. PubMed ID: 7582477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
    Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
    Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
    Moorman JM; Leslie RA
    Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ; Peroutka SJ
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
    Chaouloff F; Baudrie V; Coupry I
    Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
    Wang SJ; Wang KY; Wang WC; Sihra TS
    J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical [3H]ketanserin binding and 5-HT2A receptor-mediated behavioral responses in obese Zucker rats.
    Chaouloff F; Coupry I; Baudrie V
    Pharmacol Biochem Behav; 1995 Feb; 50(2):309-12. PubMed ID: 7740073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain.
    McKenna DJ; Nazarali AJ; Himeno A; Saavedra JM
    Neuropsychopharmacology; 1989 Mar; 2(1):81-7. PubMed ID: 2803482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation.
    Valdez M; Burke TF; Hensler JG
    Brain Res; 2002 Dec; 957(1):174-82. PubMed ID: 12443993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
    Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
    Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM; Munzar P; Beardsley PM
    Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central 5-hydroxytryptamine receptor-linked protein kinase C translocation: a functional postsynaptic signal transduction system.
    Wang HY; Friedman E
    Mol Pharmacol; 1990 Jan; 37(1):75-9. PubMed ID: 2300046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
    Cabrera TM; Battaglia G
    J Pharmacol Exp Ther; 1994 May; 269(2):637-45. PubMed ID: 8182530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
    Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
    Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.